Design considerations in the synthesis of peptides
In this article we detail some of the design considerations we use in peptides synthesis. This article is available to view here.
In this article we detail some of the design considerations we use in peptides synthesis. This article is available to view here.
Exenatide is a synthetic 39-amino acid peptide used in the treatment of insulin-treated type 2 diabetes. This GLP-1 analogue is resistant to enzymatic degradation unlike the human Glucagon-Like Peptide-1 (GLP-1) peptide.